The initial two-thirds of CVS’s (CVSG) financial year started well, with like-for-like sales rising by 8 per cent. But the outbreak of Covid-19 and subsequent lockdown dealt a blow to the veterinary group’s small-animal, specialist referral and equine revenue streams – leading growth to temper to just 0.7 per cent for the full reporting period to June.
IC TIP:
Buy
at
1170p